Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Taxane”

449 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 449 results

Not applicableUnknownNCT03979911
What this trial is testing

Evaluation of Pertuzumab-Trastuzumab and Taxane in the Standard Treatment of Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsHER-2 Gene Amplification
University Hospital, Brest 63
Not applicableStudy completedNCT07148336
What this trial is testing

Identification of Chemotherapy-induced Peripheral Neuropathy

Who this might be right for
Breast Cancer
University Hospital Schleswig-Holstein 26
Early research (Phase 1)UnknownNCT05013268
What this trial is testing

Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinoma

Who this might be right for
Cervical Squamous Cell Carcinoma
Ruijin Hospital 15
Testing effectiveness (Phase 2)UnknownNCT02829008
What this trial is testing

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Chinese Academy of Medical Sciences 120
Large-scale testing (Phase 3)Study completedNCT00262990
What this trial is testing

Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
Novartis Pharmaceuticals 829
Testing effectiveness (Phase 2)Ended earlyNCT05336721
What this trial is testing

A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC

Who this might be right for
Triple-negative Breast Cancer
Chipscreen Biosciences, Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT01019577
What this trial is testing

Clinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and Who Are Taxane Resistant

Who this might be right for
Metastatic Breast Cancer
R-Pharm 54
Large-scale testing (Phase 3)Active Not RecruitingNCT06382142
What this trial is testing

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02)

Who this might be right for
Triple-Negative Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 418
Large-scale testing (Phase 3)Active Not RecruitingNCT06519370
What this trial is testing

FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 350
Early research (Phase 1)UnknownNCT00049244
What this trial is testing

BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
R-Pharm
Testing effectiveness (Phase 2)Active Not RecruitingNCT04592237
What this trial is testing

Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
M.D. Anderson Cancer Center 120
Large-scale testing (Phase 3)Study completedNCT00017095
What this trial is testing

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,856
Large-scale testing (Phase 3)Ended earlyNCT01641939
What this trial is testing

Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 415
Not applicableNot Yet RecruitingNCT07511569
What this trial is testing

Prospective Exploratory Study of a Multiomic Blood Biomarker Panel to Predict Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Who this might be right for
Chemotherapy Induced Neuropathic PainNeuropathy ToxicTaxane-induced Peripheral Neuropathy+1 more
Centre Hospitalier de Bligny 192
Not applicableWithdrawnNCT01692483
What this trial is testing

Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Neoplasms
Janssen Pharmaceutica
Testing effectiveness (Phase 2)UnknownNCT06524609
What this trial is testing

EGCG for the Prevention and Treatment of TIPN

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Han Xi Zhao 36
Not applicableStudy completedNCT07105553
What this trial is testing

Glove Compression for Chemotherapy-Induced Neuropathy

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy (CIPN)Gynecologic CancersOvarian Cancer (OvCa)+1 more
Ankara Etlik City Hospital 76
Not applicableNot Yet RecruitingNCT07823725
What this trial is testing

TailorDose Lung: Decentralized TDM of Taxanes and ALK Inhibitors Using Capillary Self-Sampling

Who this might be right for
Non-Small Cell Lung Cancer (MeSH Term: Carcinoma, Non-Small-Cell Lung)
Karolinska Institutet 40
Large-scale testing (Phase 3)Looking for participantsNCT05862064
What this trial is testing

A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 606
Large-scale testing (Phase 3)Study completedNCT00103233
What this trial is testing

Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network
Next Page